BIOMERIEUX — Ethics & Boards

Corporation with Board of Directors
Marcy l'Etoile, France
Closing date: December 31
Date of the Last Annual General Meeting: May 23, 2022
- CAC Next 20 ,
- Eurozone 300 ,
- SBF 120 ,
- SBF 80 ,
- STOXX®Europe 600
- E&B Pharmaceuticals & Biotechnology ,
- E&B Tech Leaders Europe
- DJSI World ,
- Euro Stoxx Sustainability ,
- Stoxx Global ESG Leaders ,
- DJSI Europe ,
- Eurozone 120

Governance leadership structure

Board of Directors

Alexandre MÉRIEUX
Chair
Since over 5 years

Other directorships

9 voting members and 1 non-voting

Independents
Executives
Employees representatives
State representatives
Other

Directors
average seniority 10.3 years
11.5 years for elected by shareholders

Directors
average age - years
60.4 years for elected by shareholders

Chair and CEO roles are combined:
Is there a Lead Independent Director?	No
Is the Nomination committee Chair independent?	Yes
Is there a 2/3 majority of independent Directors in the Audit Committee?	Yes

8 members

Executive Committee

Alexandre MÉRIEUX
Chief Executive Officer
Since over 5 years
Other directorships

61.4 % Percentage of variable remunerations in 2021 Global compensation

Board & Leadership

Board of Directors

Your Internet Explorer version is outdated. Upgrade it, or download Google Chrome for a better experience.